WANG Lihua, WANG Yi, PENG Chao, RAN Dongchuan, HE Yan. Changes of tumor markers after blood glucosecontrol in patients with type 2 diabetes mellitus and influencing factors[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 91-95. DOI: 10.7619/jcmp.20200919
Citation: WANG Lihua, WANG Yi, PENG Chao, RAN Dongchuan, HE Yan. Changes of tumor markers after blood glucosecontrol in patients with type 2 diabetes mellitus and influencing factors[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 91-95. DOI: 10.7619/jcmp.20200919

Changes of tumor markers after blood glucosecontrol in patients with type 2 diabetes mellitus and influencing factors

More Information
  • Received Date: September 21, 2020
  • Available Online: March 22, 2021
  • Published Date: March 14, 2021
  •   Objective  To observe the dynamic changes of alpha fetoprotein(AFP), cancer embryonic antigen(CEA), cancer antigen 15-3(CA15-3), cancer antigen 19-9(CA19-9) and cancer antigen 72-4(CA72-4) after blood glucose control in type 2 diabetic patients and to analyze the influencing factors.
      Methods  A total of 540 patients with type 2 diabetes were randomly selected as diabetes group, and 300 age-matched healthy people with physical examinations were enrolled into healthy group. The levels of tumor markers between the two groups were compared, and then subgroup analysis was performed based on subjects'age and different HbA1c level. Serum tumor markers of subgroups were compared. The related indicators one month after blood glucose control were rechecked, and multiple Logistic regression analysis was performed for other confounding factors that may affect the level of tumor markers.
      Results  CEA and CA19-9 levels of patients in the diabetes group were significantly higher than those in the healthy group (P < 0.05), and AFP, CA15-3 and CA72-4 levels showed no statistically significant differences between the two groups (P>0.05). Subgroup analysis showed that the higher the blood glucose and the older the age was, the higher the CEA and CA19-9 levels would be, which showed statistically significant between-group differences (P < 0.05). One month after the blood glucose control reaching the standard, the reexamination results of the diabetes group showed that the levels of serum CEA and CA19-9 after control were lower than before the control(P < 0.05). Multiple Logistic regression analysis showed that elder age, longer course of diabetes, smoking and alcohol drinking were all risk factors for the increase of serum CEA and CA19-9 levels, and alcohol drinking was a risk factor for the increase of serum AFP level. Body mass index (BMI), serum creatinine, albumin, triglyceride and low density lipoprotein cholesterol levels showed no correlations with serum tumor markers.
      Conclusion  Before reaching the goal of blood glucose control, the level of serum tumor markers in patients with type 2 diabetes may be increased to a certain extent. Relevant indicators should be fully evaluated clinically, the primary disease should be actively treated, long-term follow-up observation should be performed so as to avoid missed diagnosis.
  • [1]
    SAEEDI P, PETERSOHN I, SALPEA P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pract, 2019, 157: 107843. doi: 10.1016/j.diabres.2019.107843
    [2]
    严宝湖, 蔡玥, 薛明, 等. 2010与2017年中国城市和农村主要慢性病可避免死亡率的比较研究[J]. 中华预防医学杂志, 2020, 54(6): 679-684. doi: 10.3760/cma.j.cn112150-20190927-00756
    [3]
    MATTIUZZI C, LIPPI G. Current cancer epidemiology[J]. J Epidemiol Glob Health, 2019, 9(4): 217-222. doi: 10.2991/jegh.k.191008.001
    [4]
    LUO S, LI J Y, ZHAO L N, et al. Diabetes mellitus increases the risk of colorectal neoplasia: an updated meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2016, 40(1): 110-123. doi: 10.1016/j.clinre.2015.05.021
    [5]
    LIAW Y P, KO P C, JAN S R, et al. Implications of Type1/2 diabetes mellitus in breast cancer development: a general female population-based cohort study[J]. J Cancer, 2015, 6(8): 734-739. doi: 10.7150/jca.12197
    [6]
    GIOVANNUCCI E, HARLAN D M, ARCHER M C, et al. Diabetes and Cancer: a consensus report[J]. Diabetes Care, 2010, 33(7): 1674-1685. doi: 10.2337/dc10-0666
    [7]
    TSILIDIS K K, KASIMIS J C, LOPEZ D S, et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies[J]. BMJ, 2015, 350: g7607. doi: 10.1136/bmj.g7607
    [8]
    PEARSON-STUTTARD J, ZHOU B, KONTIS V, et al. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment[J]. Lancet Diabetes Endocrinol, 2018, 6(6): e6-e15. doi: 10.1016/S2213-8587(18)30150-5
    [9]
    VIGNERI P, FRASCA F, SCIACCA L, et al. Diabetes and cancer[J]. Endocr - Relat Cancer, 2009, 16(4): 1103-1123. doi: 10.1677/ERC-09-0087
    [10]
    叶涛, 邹海珠, 陶栎箫, 等. 2型糖尿病患者血清肿瘤标志物CA19-9、CEA与HbA1c、血糖、C肽及脂类的相关分析[J]. 暨南大学学报: 自然科学与医学版, 2020, 41(1): 58-63. https://www.cnki.com.cn/Article/CJFDTOTAL-JNDX202001007.htm
    [11]
    蒋斌, 沈山梅, 金露, 等. 2型糖尿病患者肿瘤标志物水平及其影响因素研究[J]. 中国全科医学, 2017, 20(32): 3983-3990. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX201732003.htm
    [12]
    THOMAS P, TOTH C A, SAINI K S, et al. The structure, metabolism and function of the carcinoembryonic antigen gene family[J]. Biochim Biophys Acta, 1990, 1032(2/3): 177-189. http://www.ncbi.nlm.nih.gov/pubmed/2261493
    [13]
    GANGULY A, YELTSIN E, ROBBINS J. Identification of a carcinoembryonic antigen binding protein on monocytes[J]. Biochem Biophys Res Commun, 2003, 311(2): 319-323. doi: 10.1016/j.bbrc.2003.09.213
    [14]
    LEE J Y, LEE D C, LEE J W. Serum carcinoembryonic antigen is associated with non-alcoholic fatty liver disease in healthy Korean non-smokers[J]. Clin Chem Lab Med, 2013, 51(7): 1499-1504. doi: 10.1515/cclm-2012-0585
    [15]
    DEL BENE A, CIOLLI L, BORGHERESI L, et al. Is type 2 diabetes related to leukoaraiosis? an updated review[J]. Acta Neurol Scand, 2015, 132(3): 147-155. doi: 10.1111/ane.12398
    [16]
    POLLAK M. Insulin and insulin-like growth factor signalling in neoplasia[J]. Nat Rev Cancer, 2008, 8(12): 915-928. doi: 10.1038/nrc2536
    [17]
    CLEMMONS D R, MAILE L A, LING Y, et al. Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress[J]. Growth Horm IGF Res, 2007, 17(4): 265-270. doi: 10.1016/j.ghir.2007.01.004
    [18]
    DONATH M Y, SCHUMANN D M, FAULENBACH M, et al. Islet inflammation in type 2 diabetes: from metabolic stress to therapy[J]. Diabetes Care, 2008, 31(Suppl 2): S161-S164. http://www.ncbi.nlm.nih.gov/pubmed/18227479
    [19]
    LOEB S, GONZALEZ C M, ROEHL K A, et al. Pathological characteristics of prostate cancer detected through prostate specific antigen based screening[J]. J Urol, 2006, 175(3 pt 1): 902-906. http://europepmc.org/abstract/MED/16469576
  • Related Articles

    [1]JI Tianbo, JIANG Xueling, WANG Yu, FAN Luodan, HE Dan. A review of fall fear in patients with visual impairment[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 144-148. DOI: 10.7619/jcmp.20244178
    [2]LI Zeyu, HUANG Zixu, XU Jingxuan, YUAN Qiongqiong, SONG Zongming. Influencing factors of prognostic vision of affected eyes in acute retinal necrosis syndrome[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 52-58. DOI: 10.7619/jcmp.20231345
    [3]LI Shuqin, WANG Aiping. Research progress of management services for the elderly with visual impairment[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 129-132. DOI: 10.7619/jcmp.20210841
    [4]WANG Run, ZHAO Lian, MA Ke, SHI Jingdi. Effect of limbal stem cell transplantation versus amniotic membrane transplantation in treating pterygium[J]. Journal of Clinical Medicine in Practice, 2021, 25(12): 5-8. DOI: 10.7619/jcmp.20210381
    [5]LIU Yanzhang, ZHENG Xueli. Influence of phacoemulsification with 2.2 mm and 3.0 mm corneal incisions on postoperative corneal refractive power and astigmatism[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 76-79. DOI: 10.7619/jcmp.202022022
    [6]ZHU Qiaoping. Effect of retinal laser photocoagulation combined with intravitreal injection of conbercept on visual acuity of patients with neovascular glaucoma[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 55-58. DOI: 10.7619/jcmp.202012016
    [7]CHAO Yuanyuan, GOU Qi, WANG Xia. Influence of visual perception training combined with nursing intervention on visual acuity and diopter of children aged 3 to 6 years with myopic amblyopia[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 111-114. DOI: 10.7619/jcmp.201921032
    [8]FU Jinjing, ZHAO Yunhe, ZHU Jiali, HUI Jing, FENG Yuejuan, LI Chunyan. Vision rehabilitation of low vision children aged6 to 14 years old by treatment of refractive correction and wearing of visual aids[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 75-77, 81. DOI: 10.7619/jcmp.201913021
    [9]LYU Yue'e, XIONG Yongqiang. Effect observation of visual perception training on improving visual acuity and stereopsis function in children with amblyopia[J]. Journal of Clinical Medicine in Practice, 2018, (19): 109-111. DOI: 10.7619/jcmp.201819031
    [10]PENG Jingying, ZHANG Junjun, JIANG Xiaoshuang, LI Ruifeng, LI Ling. Correlation between cilioretinal artery and central visual impairment in patients with central retinal artery occlusion[J]. Journal of Clinical Medicine in Practice, 2017, (7): 102-104. DOI: 10.7619/jcmp.201707028

Catalog

    Article views (591) PDF downloads (20) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return